...
首页> 外文期刊>The Journal of Clinical Investigation: The Official Journal of the American Society for Clinical Investigation >Current therapies and future possibilities for drug development against liver-stage malaria
【24h】

Current therapies and future possibilities for drug development against liver-stage malaria

机译:针对肝期疟疾的药物开发的当前疗法和未来可能性

获取原文
获取原文并翻译 | 示例
           

摘要

Malaria remains a global public health threat, with half of the world's population at risk. Despite numerous efforts in the past decade to develop new antimalarial drugs to surmount increasing resistance to common therapies, challenges remain in the expansion of the current antimalarial arsenal for the elimination of this disease. The requirement of prophylactic and radical cure activities for the next generation of antimalarial drugs demands that new research models be developed to support the investigation of the elusive liver stage of the malaria parasite. In this Review, we revisit current antimalarial therapies and discuss recent advances for in vitro and in vivo malaria research models of the liver stage and their importance in probing parasite biology and the discovery of novel drug candidates.
机译:疟疾仍然是一个全球公共卫生威胁,世界上一半的人口处于危险之中。尽管在过去十年中为开发新的抗疟药物以克服对常见疗法日益增长的耐药性做出了许多努力,但在扩大现有抗疟武器库以消除这种疾病方面仍然存在挑战。下一代抗疟药物的预防性和根治性治疗活动的要求要求开发新的研究模式,以支持对疟疾寄生虫难以捉摸的肝脏阶段的调查。在这篇综述中,我们回顾了目前的抗疟疗法,并讨论了肝脏阶段的体外和体内疟疾研究模型的最新进展及其在探索寄生虫生物学和发现新型候选药物方面的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号